109.80 USD
▼-1.27-2.66%
2026-08-03
市值
$11.87B
市盈率
242.03
EPS
0.45
股息率
—
52 周区间
28.66 – 122.21
成交量
1.27M
Beta
0.46
目标价
135.25
52W 低 28.6652W 高 122.21
价格走势
公司简介
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing’s syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. It also develops relacorilant, a selective cortis...